Contract 75N93022C00001
Ppd Development Lp · Department Of Health And Human Services · August 7, 2024
Ppd Development Lp was awarded a federal contract by Department Of Health And Human Services (National Institutes Of Health) on August 7, 2024 for $2.88 million of work in research and development in biotechnology (except nanobiotechnology). Performance is in Wilmington, NC. It was awarded under full and open competition. The contract has been modified 5 times since the base award It uses cost-plus contract pricing. The most recent modification was on February 11, 2026. If all options are exercised, the contract could reach $29.12 million.
Contract details
- PIID
- 75N93022C00001
- Award type
- Definitive Contract
- Pricing
- Cost Plus Fixed Fee
- Set-aside
- No Set Aside Used.
- Competition
- Full And Open Competition
- NAICS
- 541714 · Research And Development In Biotechnology (Except Nanobiotechnology)
- Product / service
- Health R&D Services; Health Care Services; Applied Research
- Place of performance
- Wilmington, NC
- First action
- August 7, 2024
- Latest action
- February 11, 2026
Description
REGULATORY MANAGEMENT CENTER (RMC)
Modification timeline
-
February 11, 2026Mod P00019 · Other Administrative Action$17.43M
-
November 24, 2025Mod P00018 · Funding Only Action$17.43M
-
October 30, 2025Mod P00017 · Exercise An Option$14.55M
-
August 23, 2024Mod P00015 · Other Administrative Action$11.60M
-
August 15, 2024Mod P00014 · Exercise An Option$12.23M
-
August 7, 2024Mod P00013 · Other Administrative Action$11.60M
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Vericel Corporation | Department Of Health And Human Services | April 1, 2026 | $34.88M |
| Pattern Bioscience, Inc. | Department Of Health And Human Services | March 31, 2026 | $22.50M |
| Ceramedix Holding, Llc | Department Of Health And Human Services | March 31, 2026 | $4.22M |
| Glaxosmithkline, Llc | Department Of Health And Human Services | March 31, 2026 | $7.79M |
| Care Access Research Llc | Department Of Health And Human Services | March 31, 2026 | $2.55M |
| American College Of Medical Toxicology, Inc. | Department Of Health And Human Services | March 31, 2026 | $0 |
Top contractors in NAICS 541714
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Amgen USA Inc | 1 | $59.99M |
| 2 | Vericel Corporation | 1 | $34.88M |
| 3 | Spectral Md, Inc. | 1 | $31.67M |
| 4 | Ppd Development Lp | 6 | $31.12M |
| 5 | L3 Technologies, Inc. | 1 | $22.00M |
| 6 | Technical Resources International, Inc. | 6 | $21.80M |
| 7 | Abbott Laboratories | 1 | $21.01M |
| 8 | Paratek Pharmaceuticals, Inc | 1 | $17.47M |
| 9 | Ossium Health, Inc. | 1 | $12.39M |
| 10 | Rho Federal Systems Division Inc | 1 | $8.00M |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract 75N93022C00001?
Contract 75N93022C00001 is a federal contract awarded to Ppd Development Lp by Department Of Health And Human Services on August 7, 2024 for $2.88 million of work classified under RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY). It has been modified 5 times since the base award.
Who won contract 75N93022C00001?
Ppd Development Lp won contract 75N93022C00001 from Department Of Health And Human Services.
How much is contract 75N93022C00001 worth?
Contract 75N93022C00001 has obligated $2.88 million to date, with a total potential value of $29.12 million if all options are exercised.